2017 American Transplant Congress
Evaluation of Outcomes in Renal Transplantation Using Machine Perfusion for the Preservation of Kidneys from Expanded Criteria Donor.
Agence de la Biomedecine, Saint Denis La Plaine, France
Introduction:The shortage of kidney grafts led to retrieve organs from old donors with one or more co-morbidities, considered as “expanded criteria donors” (ECD). In France,…2017 American Transplant Congress
Transplant without Borders – A New Project for Decentralization of Transplant Centers in Brazil.
Organ Transplantation, Bandeirantes Hospital, Sao Paulo, Brazil
The regional disparity in transplant activity is one of the main problems in Brazil and in other countries. Brazilian transplant centers are concentrated in the…2017 American Transplant Congress
Protocol of the KTFT-TALK Study to Reduce Racial Disparities in Kidney Transplant Evaluation and Living Donor Kidney Transplantation.
Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). But, the evaluation process for a kidney transplant is complex, time…2017 American Transplant Congress
Accuracy of Computed Tomography for Detecting Hepatic Steatosis in Donors for Liver Transplantation.
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Background: The accuracy of computed tomography (CT) for detecting donor hepatic steatosis (HS) before liver transplantation is not well established.Methods: A meta-analysis was performed to…2017 American Transplant Congress
Primary Graft Dysfunction Post Heart Transplantation: Is There Greater Risk for De Novo Donor-Specific Antibody Development?
Cedars-Sinai Heart Institute, Los Angeles
Background: Primary graft dysfunction (PGD) may occur in up to 30% of heart transplant recipients and has been associated with increased mortality. The development of…2017 American Transplant Congress
A Novel Role for MyD88 Signaling Downstream from Toll-Like Receptors in B Cells Responding to Blood Group Antigens.
Hiroshima University, Hiroshima, Japan
[Introduction]Although there is some empirical evidence that severe infectious complications provoke refractory AMR following ABO-incompatible transplantations (ABOi-Tx), its mechanism remains unclear. Here, we investigated a…2017 American Transplant Congress
Polypharmacy and Frailty in Kidney Transplant Recipients.
Department of Surgery, Johns Hopkins Medicine Institute, Baltimore, MD
Frailty is common in kidney transplant (KT) recipients with a prevalence of 20%, and is associated with post-KT adverse events including mortality, DGF, early hospital…2017 American Transplant Congress
Very Long Term Graft Survival. Forecasts Factors.
Nephrology, Hospital Ramon y Cajal, Madrid, Spain
Introduction: Kidney transplantation is the best treatment for end-stage renal failure. Between 2 and 5% of transplanted grafts are lost each year and only a…2017 American Transplant Congress
TNF[part]-I After Kidney Transplantation.
Department of Medicine, Division of Nephrology, University of Wisconsin, Madison, WI
Infliximab, adalimumab and etanercept are monoclonal antibodies which inhibit tumor necrosis factor alpha (TNF[part]-I) and are used in the treatment of inflammatory diseases such as…2017 American Transplant Congress
Liver Transplantation Using Pediatric versus Adult Donor Grafts in Adult Recipients.
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Background: The reported outcomes of adult liver transplantation using pediatric livers are largely controversial based on single center studies. We aimed to answer this clinical…
- « Previous Page
- 1
- …
- 97
- 98
- 99
- 100
- 101
- …
- 181
- Next Page »